Effect of levosimendan on E/E′ ratio in patients with ischemic heart failure
Articles > Article · 2007
Authors: Hamza DUYGU, Filiz ÖZERKAN ÇAKAN, Sanem NALBANTGİL, Mehdi ZOGHİ, Azem AKILLI, Mustafa Akin, Cem NAZLI, Oktay ERGENE
International Journal of Cardiology, Journal Indexed in SCI Expanded, International, WoS, 2007, vol 123, pp 201-203
DOI: 10.1016/j.ijcard.2006.11.145
Summary
Background: Levosimendan is a novel positive inotropic calcium sensitizer agent used in acute heart failure. In acute heart failure, it improves hemodynamic parameters more favorably than the conventional positive inotropes. In this study, the effect levosimendan on E/E' ratio as a non-invasive indicator of LV filling pressure was evaluated compared to dobutamine in a prospective, randomized, patient-blind manner.